Interestingly, signals via DAP12 transmit sufficient activating signals to overcome protective levels of HLA class I on solid tumor cells, including glioma cells, as previously shown by our group when using a DAP12-based CAR [25,26]. This evidence concerns the gene TYROBP and glioma.